AMP Energy India commissions 5 MW solar power project for pharma company BSV

New Delhi: AMP Energy India commissioned a 5 MW solar power plant for vaccine biopharmaceutical major BSV, the company said in a statement.

The solar project, commissioned in the last quarter of 2022, supplies solar power from AMP’s open access facility in Osmanabad district to BSV’s manufacturing facility in Ambernath, Maharashtra.

The partnership will meet approximately 65% ​​of BSV’s annual energy needs helping it achieve 35% savings on its overall energy cost on a year-on-year basis.

“We believe that this partnership will provide the right impetus to the pharmaceutical industry to become environment conscious and switch to RE to reduce their energy costs and meet their sustainability goals as BSV is a leading biotech and pharmaceutical company in India. is,” said Pinaki Bhattacharya MD & CEO AMP Energy India.

“We are the most sought-after renewable energy transition partner for Pharma and Healthcare companies in India and are currently serving around 7 customers in this category. We would also like to express our gratitude to the BSV team for their support in timely delivery of the project.”

“As we commit to building a future-ready and sustainable BSV, we are confident that our efforts to reduce our carbon footprint will enable us to achieve our sustainability goals and achieve 40% of non-installed electricity capacity contribute to our country’s commitment to fossil energy sources by 2030. Through this partnership with Amp Energy India, we reaffirm our efforts towards mitigating the effects of climate change,” said Chirag Mehta, Chief Financial Officer, BSV.

The plant will also help reduce approximately 6,560 metric tons of CO2 per year, ensuring BSV meets one of its sustainability goals through carbon mitigation.

catch all corporate news And updates on Live Mint. download mint news app to receive daily market update & Live business News,